Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy.
subject: covid-19, SARS-CoV-2, encephalitis, MRI, Brain
creator: Josef Finsterer
source: Acta neurologica Belgica
date: 2021